Valiant Laboratories Limited has informed the Exchange about Allotment of Equity Shares on Rights Basis
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Valiant Laboratories has completed its rights issue, allotting 1,08,62,500 equity shares at ₹75 per share (face value ₹10 + premium ₹65), aggregating to ₹8,146.88 lakhs (~₹81.47 crores). The rights issue opened on July 28, 2025 and closed on August 8, 2025, with full subscription. As a result, the company's paid-up equity share capital has increased from ₹43.45 crores (4.34 crore shares) to ₹54.31 crores (5.43 crore shares), a rise of about 25% in share count. The shares will be credited to allottees' demat accounts in due course.
The rights issue is fully subscribed, which is positive as it shows shareholder confidence and strengthens the company's capital base. However, existing shareholders who did not subscribe will face dilution of their holding by roughly 25%.